UnitedHealth (UNH) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended March 2025, UnitedHealth Group (UNH) reported revenue of $109.58 billion, up 9.8% over the same period last year. EPS came in at $7.20, compared to $6.91 in the year-ago quarter.The reported revenue represents a surprise of -1.40% over the Zacks Consensus Estimate of $111.13 billion. With the consensus EPS estimate being $7.27, the EPS surprise was -0.96%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how UnitedHealth performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Operating Statistics - Medical Care Ratio: 84.8% versus 85.9% estimated by nine analysts on average. UnitedHealthcare Customer Profile - People Served - Commercial - Domestic- Risk-based: 8.41 million compared to the 9 million average estimate based on five analysts. UnitedHealthcare Customer Profile - People Served - Commercial - Domestic- Fee-based: 21.59 million versus the five-analyst average estimate of 21.46 million. UnitedHealthcare Customer Profile - People Served - Total Community and Senior: 20.13 million compared to the 20.16 million average estimate based on five analysts. Revenues- Investment and other income: $1.03 billion compared to the $1.06 billion average estimate based on 10 analysts. The reported number represents a change of +2.2% year over year. Revenues- Products: $13.04 billion versus the 10-analyst average estimate of $13.33 billion. The reported number represents a year-over-year change of +9.5%. Revenues- Services: $8.97 billion compared to the $9.76 billion average estimate based on 10 analysts. The reported number represents a change of +1% year over year. Revenues- Premiums: $86.53 billion versus the 10-analyst average estimate of $86.94 billion. The reported number represents a year-over-year change of +11%. Revenues- Optum Insight: $4.63 billion versus $5.11 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +2.8% change. Revenues- Optum Rx: $35.13 billion versus $34.11 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +13.9% change. Revenues- Optum Health: $25.31 billion compared to the $28.97 billion average estimate based on six analysts. The reported number represents a change of -5.3% year over year. Revenues- UnitedHealthcare- Total: $84.62 billion versus the six-analyst average estimate of $83.20 billion. The reported number represents a year-over-year change of +12.3%. View all Key Company Metrics for UnitedHealth here>>>Shares of UnitedHealth have returned +16.3% over the past month versus the Zacks S&P 500 composite's -6.3% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks